Tandem Health Competitive Intelligence & Landscape

Tandem Health (tandemhealth.ai) is an innovative company providing an AI assistant designed to support healthcare professionals across Europe. Founded in 2023 by Lukas Saari and Oliver Åstran, with its headquarters in Stockholm, Sweden, the company aims to restore clinician presence during patient consultations by reducing the burden of administrative tasks. Their core product, Tandem, is a regulated clinical AI solution trusted by health systems and care teams [tandemhealth.ai].

Tandem Health offers a complete AI medical assistant that helps clinicians prepare, document, and follow up on patient visits. The Tandem platform captures consultation details and automatically generates structured clinical notes, documents, and relevant diagnosis and procedure codes, such as ICD-10 and SNOMED, within seconds [tandemhealth.ai/product/overview]. It also features hands-free voice editing and personalization capabilities, learning from user edits to apply their style to subsequent notes, thereby reducing the need for corrections [tandemhealth.ai/en/].

The target market for Tandem Health includes health systems, clinicians, and care teams across Europe, supporting over 50 specialties from cardiology to nursing [tandemhealth.ai/en/].

Tandem is built by in-house clinicians who understand the daily realities of healthcare, aiming to mitigate burnout and refocus clinical time on patient care, rather than administrative work that can consume up to 40% of a clinician's day [tandemhealth.ai/about/our-story]. The company emphasizes its commitment to safety and compliance, holding the distinction of being the first MDR Class IIa certified medical scribe [tandemhealth.ai/en/about/our-story].

Tandem Health (tandemhealth.ai) offers an AI medical assistant that helps clinicians prepare, document, and follow up on patient visits. Known as Tandem, the product functions as an AI scribe and AI medical assistant, capturing consultation details to instantly generate structured clinical notes, documents, and relevant diagnosis and procedure codes like ICD-10 and SNOMED [tandemhealth.ai]. This regulated clinical AI is trusted by health systems and care teams across Europe and is the first MDR Class IIa certified medical scribe [tandemhealth.ai/en/product/ai-scribe]. Tandem supports over 50 specialties, from cardiology to nursing, with tailored documentation [tandemhealth.ai].

Tandem Health provides both free and paid plans, with features and pricing that may vary by region and are subject to change [tandemhealth.ai/en/legal/terms-of-service]. For individual clinicians and small practices, the Pro plan is available at €125 per user/month, offering unlimited note and document generation [tandemhealth.ai/en/product/pricing]. The company also offers free trials and options to book a demo for all users [tandemhealth.ai]. Tandem Health aims to serve a wide range of users, from solo practitioners to large organizations, with its service already utilized by over 5,000 care organizations across Europe [tandemhealth.ai/en/product/pricing].

Recent features highlight Tandem's focus on personalization, with the system learning and applying a user's editing style to new notes, minimizing the need for manual fixes over time [tandemhealth.ai]. The platform is designed with robust data security, being MDR Class IIa certified for its AI Scribe and Coding Assistant, and holding ISO 13485 and ISO 27001 certifications. It also complies with GDPR and local patient data protection laws, including NHS data security standards, making it highly secure for European healthcare environments [tandemhealth.ai/product/data-security]. Integrations with over 100 medical record systems, such as QMed, allow for direct transfer of clinical documentation into EHR/EMR systems, streamlining workflows for clinicians [tandemhealth.ai/product/integrations/qmed].

Tandem Health (tandemhealth.ai) is actively expanding its team, signaling a robust growth strategy focused on enhancing its AI-powered clinical decision support and documentation solutions. The company states, "At Tandem, we build AI that gives clinicians time back. Our team includes doctors, psychologists, and AI engineers," emphasizing a multidisciplinary approach to developing regulated clinical AI trusted by health systems across Europe [tandemhealth.ai/about/careers]. This commitment to a diverse talent pool, including medical professionals and AI specialists, underscores their dedication to creating clinically relevant and technologically advanced healthcare solutions.

The company's hiring patterns reveal a strategic emphasis on expanding its presence and expertise in key European markets. Notably, Tandem Health announced the appointment of Heidi Stensmyren to strengthen AI adoption in European healthcare and expanded to Finland with Dr. Johan Sanmark as Country Director in late 2025 [tandemhealth.ai/resources/news]. These strategic hires, particularly in leadership roles and new market entries, indicate a strong push for market penetration and establishing local expertise. Furthermore, Tandem Health currently employs over 120 individuals, with a significant portion of its team comprising over 50 doctors, psychologists, and pharmacists who bring clinical experience to their operations [tandemhealth.ai/da/om-os/karriere, tandemhealth.ai/about/clinical-team].

Tandem Health is continuously seeking new talent across various departments, including Product, Operations, and Go-to-market functions [tandemhealth.ai/about/our-story]. This broad recruitment effort highlights the company's commitment to scaling its operations and developing its product offerings. The job openings, available across different regions like Denmark and Finland [tandemhealth.ai/da/om-os/karriere, tandemhealth.ai/fi/recruitment?ashby_jid=0c2442f0-7171-48e5-a894-13066c9340ef], reflect a dynamic strategy to support its growing user base of over 5,000 care organizations in Europe. No information regarding layoffs was found, indicating a stable and expanding workforce.

The company’s consistent hiring and strategic appointments, particularly in clinical and regional leadership roles, are strong indicators of its confidence in its regulated clinical AI solutions and its ambitious expansion plans within the European healthcare sector. The focus on integrating clinical expertise with AI engineering expertise directly supports their mission of "restoring presence" for clinicians by reducing administrative burdens and improving patient interaction [tandemhealth.ai].

Tandem Health has demonstrated significant financial momentum through successful fundraising rounds. The company secured a Seed round of $9.5 million on June 19, 2024, to scale its healthcare co-pilot. This initial investment was led by global VC firm Northzone, with additional participation from angel operators from OpenAI & DeepMind, the founder of Capio, and healthcare VC Amin [tandemhealth.ai/resources/news/tandem-health-raises-9.5m-to-scale-its-healthcare-co-pilot]. This funding was crucial for advancing its AI assistant designed to reduce administrative burdens for clinicians across various specialties.

Building on this early success, Tandem Health announced a $50 million Series A funding round on June 30, 2025 [tandemhealth.ai/resources/news/tandem-health-secures-50m-to-build-an-ai-native-operating-system-for-clinical-workflows-across-europe]. This substantial investment was led by Kinnevik, with continued support from Northzone, Amino Collective, and Visionaries Club. The Series A funding provides Tandem Health with the capital to accelerate its development and establish an AI-native operating system for clinical workflows across Europe [tandemhealth.ai/en/resources/news/tandem-health-secures-50m-to-build-an-ai-native-operating-system-for-clinical-workflows-across-europe].

While specific revenue figures for Tandem Health are not publicly disclosed, the company's rapid fundraising indicates strong investor confidence in its business model and market potential.

Tandem Health serves over 5,000 care organizations across Europe and integrates with more than 100 electronic health record systems, including major platforms like Epic and EMIS [tandemhealth.ai/en/resources/news/building-the-ai-native-operating-system-for-european-clinics]. This widespread adoption suggests a growing customer base and a solid foundation for future revenue generation. There is no publicly available information regarding any M&A activities by Tandem Health to date.

Tandem Health actively participates in a variety of events, demonstrating its commitment to advancing AI in healthcare and engaging with the medical community. The company has a notable history of hosting significant figures, such as HRH Prince Daniel for a session focused on AI development in healthcare, underscoring its role in industry thought leadership [https://tandemhealth.ai/resources/news]. These events highlight Tandem Health's dedication to discussing and shaping the future of clinical AI.

Beyond hosting, Tandem Health's public presence is also visible through its ongoing partnerships and news updates, which often coincide with product announcements and milestones. For instance, the company announced the integration of wireless audio capture with the Philips SpeechMike Ambient, a development that likely involves discussions and showcases at relevant technology or healthcare events [https://tandemhealth.ai/nl/resources/nieuws/introducing-wireless-audio-capture-for-tandem-the-philips-speechmike-ambient]. Such announcements are crucial for maintaining visibility and fostering collaborations within the health tech ecosystem.

Tandem Health regularly shares insights and updates through its resources section, which includes a knowledge base featuring articles on topics like "What is an AI medical scribe?" and "Why AI scribes need to fall under EU MDR" [https://tandemhealth.ai/en/resources/knowledge]. While these are not explicit event participations, the content they produce serves as a form of virtual engagement, providing valuable information to clinicians and healthcare organizations. The company also uses these platforms to promote new features like Personalised Memories, an update that enhances its AI's ability to learn user writing styles [https://tandemhealth.ai/resources/news/tandem-health-and-cgi-partner-to-bring-ai-supported-clinical-documentation-to-finland].